References
- White AR, Enever P, Tayebi M, et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003;422:80-3
- Sigurdsson EM, Brown DR, Daniels M, et al. Immunization delays the onset of prion disease in mice. Am J Pathol 2002;161:13-17
- Sassa Y, Kataoka N, Inoshima Y, Ishiguro N. Anti-PrP antibodies detected at terminal stage of prion-affected mouse. Cell Immunol 2010;263:212-18
- Gourdain P, Gregoire S, Iken S, et al. Adoptive transfer of T lymphocytes sensitized against the prion protein attenuates prion invasion in scrapie-infected mice. J Immunol 2009;183:6619-28
- Iken S, Bachy V, Gourdain P, et al. Th2-polarized PrP-specific transgenic T-cells confer partial protection against murine scrapie. PLoS Pathog 2011;7(9):e1002216
- Bachy V, Ballerini C, Gourdain P, et al. Mouse vaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie. J Gen Virol 2010;91:809-20
- Tayebi M, Collinge J, Hawke S. Unswitched immunoglobulin M response prolongs mouse survival in prion disease. J Gen Virol 2009;90:777-82
- Alexandrenne C, Wijkhuisen A, Dkhissi F, et al. Electrotransfer of cDNA coding for a heterologous prion protein generates autoantibodies against native murine prion protein in wild-type mice. DNA Cell Biol 2010;29:121-31
- Han Y, Li Y, Song J, et al. Immune responses in wild-type mice against prion proteins induced using a DNA prime-protein boost strategy. Biomed Environ Sci 2011;24:523-9
- Ishibashi D, Yamanaka H, Mori T, et al. Antigen mimicry-mediated anti-prion effects induced by bacterial enzyme succinylarginine dihydrolase in mice. Vaccine 2011;29:9321-8
- Maricinuik K, Maattanen P, Taschuk R, et al. Development of a multivalent, PrPSc-specific prion vaccine through rational optimization of three disease-specific epitopes. Vaccine 2014;32:1988-97
- David MA, Jones DR, Tayebi M. Potential candidate camelid antibodies for the treatment of protein-misfolding diseases. J Neuroimmunol 2014;272:76-85
- Fujita K, Yamaguchi Y, Mori T, et al. Effects of a brain-engraftable microglial cell line expressing anti-prion scFv antibodies on survival times of mice infected with scrapie prions. Cell Mol Neurobiol 2011;31:999-1008
- Bremer J, Heikenwalder M, Haybaeck J, et al. Repetitive immunization enhances the susceptibility of mice to peripherally administered prions. PLoS One 2009;4:e7160
- Solforosi L, Criado JR, McGavern DB, et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004;303:1514-16
- Klöhn P-C, Farmer M, Lineham J, et al. PrP antibodies do not trigger mouse hippocampal neuron apoptosis. Science 2012;335:52
- Tayebi M, David M, Bate C, et al. Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis. J Gen Virol 2010;91:3105-15
- Xanthopoulos K, Lagoidaki R, Kontana A, et al. Immunization with recombinant prion protein leads to partial protection in a murine model of TSEs through a novel mechanism. PLoS One 2013;8:e59143
- Sonati T, Reimann RR, Falsig J, et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 2013;501:102-6
- Goñi F, Chablagoity JA, Prelli F, et al. High titres of mucosal and systemic anti-PrP antibodies abrogates oral prion infection in mucosal vaccinated mice. Neuroscience 2008;153:679-86
- Pilon JL, Rhyan JC, Wolfe LL, et al. Immunization with a synthetic peptide vaccine fails to protect mule deer (Odocoileus hemionus) from chronic wasting disease. J Wildlife Dis 2013;49:694-8
- Dobie K, Barron R. Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and proteinase K-resistant PrPSc levels in peripheral tissues from a murine transgenic model of TSE disease. J Virol 2013;87:5895-903
- Klyubin I, Nicoll AJ, Khalili-Shirazi A, et al. Peripheral administration of a humanized anti-PrP antibody blocks Alzheimer’s disease Aβ synaptotoxicity. J Neurosci 2014;34:6140-5